Study summary · 2021 · Randomized trial
HOME BP: supported self-monitoring in primary care
Supported home monitoring produced a modest additional reduction in systolic pressure.
Summary by Vironix Health · Source review: November 11, 2026
How we select and interpret evidence
Original publication
Richard J McManus; Paul Little; Beth Stuart; Katherine Morton; James Raftery; Jo Kelly; Katherine Bradbury; Jin Zhang; Shihua Zhu; Elizabeth Murray; Carl R May; Frances S Mair; Susan Michie; Peter Smith; Rebecca Band; Emma Ogburn; Julie Allen; Cathy Rice; Jacqui Nuttall; Bryan Williams; Lucy Yardley; HOME BP investigators
Universities of Oxford, Southampton, Bristol, Glasgow and University College London; London School of Hygiene and Tropical Medicine; UK primary-care practices
The BMJ · Online: · Issue: 2021
Journal article with 2022 correction, DOI 10.1136/bmj.m2216. · Full text consulted. This article has a linked published correction.
What was studied
- Design
- Randomized trial
- Population
- Adults with treated but poorly controlled hypertension and internet access
- Sample
- 622 participants
- Intervention
- Home BP, digital feedback and clinician-directed medication titration
- Comparator
- Usual primary care
- Follow-up
- 12 months
- Setting
- United Kingdom; 76 general practices
Methods
Unmasked randomized trial with automated primary-endpoint ascertainment.
Findings
Adjusted systolic BP difference at one year was −3.4 mmHg (95% CI −6.1 to −0.8). Adverse effects were similar.
Limitations
One-year BP measurements were available for 552 of 622 participants (88.6%); missing outcomes were imputed. Internet access was required, and the intervention bundled several components. A 2022 correction fixes baseline Table 1 counts.
What this means for care delivery
Plan clinical treatment responses and assisted access alongside home measurements.